Biogen Inc. buy Needham & Company LLC
Start price
26.10.23
/
50%
€229.60
Target price
26.10.24
€289.60
Performance (%)
-17.92%
Price
02.08.24
€188.45
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -17.92%. This prediction currently runs until 26.10.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -3.086% | -3.086% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat